五洲医疗收盘下跌1.99%，滚动市盈率76.78倍，总市值27.42亿元

Core Viewpoint - Wuzhou Medical's stock closed at 40.33 yuan on August 15, experiencing a decline of 1.99%, with a rolling PE ratio of 76.78 times, and a total market capitalization of 2.742 billion yuan [1] Group 1: Company Performance - Wuzhou Medical's main business includes the research, manufacturing, and sales of disposable sterile infusion medical devices, as well as other diagnostic and nursing-related medical supplies [1] - The latest quarterly report for Q1 2025 shows the company achieved operating revenue of 104 million yuan, a year-on-year increase of 15.59%, while net profit was 5.6345 million yuan, reflecting a year-on-year decrease of 43.00%, with a sales gross margin of 14.62% [1] Group 2: Industry Comparison - The average PE ratio for the medical device industry is 56.58 times, with a median of 39.97 times, positioning Wuzhou Medical at 97th place in the industry ranking [1] - The PE ratios of other companies in the industry range from 11.36 times for Jiuan Medical to 20.86 times for Antu Biology, indicating a significant variance in valuation within the sector [2]